I Tested the 5 Biggest Big Pharma Claims Against the Evidence

Trust in medicine has become a difficult subject. Pharmaceutical companies make substantial profits, fund much of the research into their products, and have been involved in serious legal cases. At the same time, prescription medicines can prevent disability, hospital admissions and premature death for many people.

So how should patients hold both realities at once? The useful question is not whether to trust everything or trust nothing. It is how to examine health claims carefully—especially when a dramatic headline, a supplement advert or an online post seems designed to confirm what we already suspect.

Where commercial influence can shape evidence

Industry funding does not automatically make research false. But it can create conflicts of interest, and commercial interests may influence which questions are studied, what treatments are compared, which outcomes are emphasised and how results are presented.

The video explores why this matters beyond pharmaceutical companies. Food businesses, supplement brands, wellness companies and even social-media platforms can all have incentives that shape the health information people see. It also looks at an important limitation of observational research: an association between a behaviour or product and better health cannot, by itself, prove that the product caused the benefit.

Can companies control regulators and doctors?

One common concern is that pharmaceutical companies can simply buy regulatory approval. The FDA does receive industry user fees to support parts of the drug-review process, which raises legitimate questions about independence and oversight. But a fee is not the same thing as a guaranteed approval, and the approval process has important limits as well as safeguards.

The video also examines financial relationships between industry and health professionals. Research funding, consulting, educational sponsorship and other payments can create real conflicts of interest—even when no one believes they are being influenced. Yet a financial relationship alone cannot tell you whether a particular prescription was inappropriate or whether a doctor acted against a patient’s interests.

Why evidence still matters for treatment decisions

Documented pharmaceutical misconduct should not be minimised. Public legal cases show that companies can promote medicines unlawfully and fail in important responsibilities. But identifying genuine failures accurately is different from assuming that every study, doctor, regulator or medicine is fraudulent.

For adults hoping to stay healthy and independent as they age, this distinction is practical. A treatment’s value depends on the size of its likely benefit, its possible harms and a person’s starting risk—not simply on whether it comes from a drug company or is labelled “natural.” Supplements are not automatically held to a stronger evidence standard before reaching consumers.

Watch the video for a clear framework for assessing studies, headlines, medicines and supplements more consistently—and for the five questions that can help you judge a claim before you buy, share or act on it.